Morgan Stanley downgraded Bausch + Lomb (BLCO) to Equal Weight from Overweight with a $19 price target While stating that B+L is “in great shape” and the firm sees “nothing wrong,” it is just taking a breather after a strong run given the stock has rapidly moved up about 30% in the last 12 months.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BLCO:
- Bausch + Lomb (BLCO) Posts Impressive Revenue and Explores Potential Sale
- Bausch + Lomb price target raised to $24 from $20 at Citi
- Bausch + Lomb price target raised to $26 from $23 at Wells Fargo
- Bausch + Lomb price target raised to $23 from $22 at H.C. Wainwright
- Bausch + Lomb Sees Strong Growth in Q3 2024